HOUSTON, Jan. 18 /PRNewswire/ -- Dr. Lloyd Everson, M.D., vice chairman of US Oncology, was recently selected to participate in a roundtable discussion hosted by the President’s Cancer Panel on strategies for maximizing the nation’s investment in cancer. The President’s Cancer Panel is a three-person group appointed by the U.S. President to oversee the National Cancer Program, and reports directly to the president. It was created by legislative mandate as part of the National Cancer Act of 1971 when President Richard Nixon declared “the war on cancer.”
The three-member Panel is comprised of Dr. LaSalle Leffall, Jr., Panel chair and the Charles R. Drew, Professor of Surgery at Howard University College of Medicine; Lance Armstrong, founder of the Lance Armstrong Foundation; and Dr. Margaret Kripke, special assistant to the provost of the University of Texas M.D. Anderson Cancer Center.
Dr. Everson participated in the third of four roundtable meetings which was held in San Juan, Puerto Rico and led by Dr. Leffall. In addition to Dr. Everson, the diverse 15-member panel included Dr. James Doroshow, director of the Division of Cancer Treatment and Diagnosis at the National Cancer Institute; Dr. Craig Thompson, director of the Abramson Cancer Center at the University of Pennsylvania; Dr. Peter Bach, associate attending physician with the Health Outcomes Research Group at Memorial Sloan-Kettering Cancer Center; Dr. David Nathan, president emeritus of Dana-Farber Cancer Institute; Dr. Elmer Huerta, president of the American Cancer Society; Dr. Lee Newcomer, senior vice president, oncology, United Healthcare, and Paula Kim, president and founder of Translating Research Across Communities.
The Panel will host one more roundtable meeting during this year’s series, with different panelists at each forum.
Once all Panel meetings are concluded, an annual report with information from all four roundtables is given to the White House, members of the government and certain advocacy groups.
The 2007-2008 report will be presented to the White House this summer and will then be available online at the Panel’s Web site at http://pcp.cancer.gov. Minutes and a statement from each meeting are also posted on the Panel’s Web site; the statement from the San Juan meeting will be available after the first of the year.
Dr. Everson was appointed in 2006 by President Bush to the National Cancer Advisory Board (NCAB). The National Cancer Advisory Board advises, consults and makes policy recommendations to the Secretary of Health and Human Services and the Director of the National Cancer Institute on issues related to cancer. The NCAB and the President’s Cancer Panel are the only two advisory bodies at the National Institutes of Health and the U.S. Department of Health and Human Services whose board members are appointed by the President. Dr. Everson is one of 18 members appointed by the President to serve rotating six-year terms on the NCAB.
Dr. Everson has served in many roles throughout his career, including the practice of oncology and hematology, cancer research, academic and administrative medicine. He was one of the founders of US Oncology and has served in numerous capacities at the company, including president, chief operating officer and his current position of vice chairman. One of his critical contributions was the founding of the industry-leading US Oncology Research, an established community-based research operation specializing in all phases of cancer clinical trials.
He has also provided his experienced voice of leadership to national and regional organizations, including serving as president of the Association of Community Cancer Centers; chairman of the executive committee of the North Central Cancer Treatment Group; member of the National Dialogue on Cancer, now known as C-Change; member of the National Cancer Institute Board of Scientific Counselors; Medical Director of the Indiana Regional Cancer Center; clinical associate professor of Medicine, section of Oncology and Hematology at Indiana University Department of Medicine; associate chairman of the Eastern Cooperative Oncology Group; member of the Intercultural Cancer Council; and president of the Indiana Medical Oncology Society.
He is also a recipient of the University of North Dakota’s 2002 Sioux Award, the highest honor given by the Alumni Association of the University of North Dakota for achievement, service and loyalty.
About US Oncology, Inc.
US Oncology, headquartered in Houston, works closely with physicians, manufacturers and payers to identify and deliver innovative services that improve patient access to integrated cancer care in the community setting. US Oncology supports one of the nation’s largest cancer treatment and research networks with services that help participating oncologists advance care through shared best practices and all phases of research.
US Oncology’s expertise in every aspect of the cancer care delivery system-from drug development to treatment and outcomes measurement-enables the company to help increase the efficiency and safety of cancer care. According to the company’s last quarterly earnings report, US Oncology is affiliated with 1,164 physicians operating in 443 locations, including 91 radiation oncology facilities in 39 states. For more information, visit the company’s Web site, http://www.usoncology.com.
CONTACT: Kimberly Rutherford of US Oncology, Inc., +1-832-601-6193,
Kimberly.Rutherford@usoncology.com; or Elizabeth Vocke of Hill & Knowlton,
Inc., +1-813-775-6206, Elizabeth.Vocke@hillandknowlton.com, for US
Oncology, Inc.
Web site: http://www.usoncology.com/
